Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+19.6%
5Y CAGR+178.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+19.6%/yr
Annual compound
5Y CAGR
+178.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
166.2x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$251.43M+7.7%
2024$233.41M+5.4%
2023$221.51M+50.8%
2022$146.87M+82.5%
2021$80.46M+5218.0%
2020$1.51M+101.1%
2019$-142.69M-245.9%
2018$-41.26M-